Sell to Open HLTH Nov 18 2022 2.5 Put Limit at $0.10 (Good 'til Canceled) HLTH daily end of the downtrend
Technical Analysis Another oversold play with huge upside Price Target Early entry: $3.66 Breakout Entry: $4.01 Price Target 1: $5.20 (+30%) Price Target 2: 5.91 (+40%) Price Target 3: 7.88 (+96%) Analyst Target: $9 (125%) Financials/Fundamental Analysis (FA) Strong financial metric and fullu capitalised for sustainable growth. Passes all quality checks.
Cue Health is a publicly-traded San Diego, California-based healthcare technology company that develops portable diagnostic tests for at-home use. The company developed the first FDA-authorized COVID-19 diagnostic test for at-home and over-the-counter use without a prescription and physician supervision
$HLTH IPO Base pattern. relatively decent RS, trading below IPO AVWAP. actionable trade for the upcoming week as it look poised for a breakout at $13.60
After falling below Ipo price, cue health will catch a bid if the omicron headline cycles for a few weeks.
IPO intraday trading strategy idea The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long position from $19,01; stop-loss — $16,23; take-profit — $27,35/MOC price. Do not view this idea as a...